TWA
RLAY icon

TCI Wealth Advisors’s Relay Therapeutics RLAY Stock Holding History

TCI Wealth Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-205
Closed -$3.38K – 1798
2023
Q1 		$3.38K Sell
205
-207
-50% -$3.71K ﹤0.01% 1784
2022
Q4 		$6.16K Sell
412
-1
-0.2% -$19 ﹤0.01% 1390
2022
Q3 		$9K Buy
413
+1
+0.2% +$22 ﹤0.01% 1098
2022
Q2 		$7K Buy
+412
New +$8.83K ﹤0.01% 1275
2021
Q4 		– Sell
-146
Closed -$5K – 2486
2021
Q3 		$5K Buy
146
+47
+47% +$1.58K ﹤0.01% 1638
2021
Q2 		$4K Buy
99
+50
+102% +$1.65K ﹤0.01% 1621
2021
Q1 		$2K Buy
+49
New +$2.13K ﹤0.01% 1871

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

TCI Wealth Advisors's RLAY Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Relay Therapeutics (RLAY) in Q2 2023, closing a stake of 205 shares — an estimated $3.38K sold.

TCI Wealth Advisors first reported a position in RLAY in Q1 2021 and held it in 7 quarters. The position peaked at $9K in Q3 2022. 161 funds tracked by Wall St. Rank hold RLAY as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Relay Therapeutics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 205 Relay Therapeutics shares in Q2 2023, an estimated $3.38K.
  • TCI Wealth Advisors first reported a position in Relay Therapeutics in Q1 2021 and held it in 7 quarters.
  • TCI Wealth Advisors's Relay Therapeutics position peaked at $9K in Q3 2022.
  • 161 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.